U.S. markets closed

Intec Pharma Ltd (NTEC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.6200+0.2600 (+7.74%)
At close: 4:00PM EDT
3.5200 -0.10 (-2.76%)
After hours: 03:56AM EDT
Show:
Balance Sheet
Cash Flow
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Breakdown
ttm
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Total Revenue
0
0
0
0
0
Operating Expense
13,829
13,829
33,446
43,328
29,439
Operating Income
-13,829
-13,829
-33,446
-43,328
-29,439
Net Non Operating Interest Income Expense
29
29
315
829
269
Other Income Expense
-204
-204
-13,830
-941
106
Pretax Income
-14,004
-14,004
-46,961
-43,440
-29,064
Tax Provision
124
124
638
103
29
Net Income Common Stockholders
-14,128
-14,128
-47,599
-43,543
-29,093
Diluted NI Available to Com Stockholders
-14,128
-14,128
-47,599
-43,543
-29,093
Basic EPS
-
-
-28.20
-28.00
-33.00
Diluted EPS
-
-
-28.20
-28.00
-33.00
Basic Average Shares
-
-
1,689
1,560
883
Diluted Average Shares
-
-
1,689
1,560
883
Total Operating Income as Reported
-13,829
-13,829
-47,109
-43,328
-29,221
Rent Expense Supplemental
-
-
-
-
253
Total Expenses
13,829
13,829
33,446
43,328
29,439
Net Income from Continuing & Discontinued Operation
-14,128
-14,128
-47,599
-43,543
-29,093
Normalized Income
-13,971
-13,971
-36,950
-42,818
-29,008
Interest Income
39
39
330
852
286
Interest Expense
-
-
15
23
17
Net Interest Income
29
29
315
829
269
EBIT
-13,829
-13,829
-33,446
-43,328
-29,439
EBITDA
-12,626
-
-
-
-
Reconciled Depreciation
1,203
1,203
854
859
829
Net Income from Continuing Operation Net Minority Interest
-14,128
-14,128
-47,599
-43,543
-29,093
Total Unusual Items Excluding Goodwill
-204
-204
-13,830
-941
-112
Total Unusual Items
-204
-204
-13,830
-941
-112
Normalized EBITDA
-12,422
-12,422
-18,762
-41,528
-28,498
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-46.92
-46.92
-3,181
-216.43
-26.88